BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Revenue 2019–2025
BridgeBio Pharma, Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BridgeBio Pharma, Inc. revenue for the quarter ending March 31, 2026 was 194.5 M, a 66.78% increase year-over-year.
- BridgeBio Pharma, Inc. revenue for the twelve months ending March 31, 2026 was 542.4 M, a 146.43% increase year-over-year.
- BridgeBio Pharma, Inc. annual revenue for 2025 was 502.1 M, a 126.26% increase from 2024.
- BridgeBio Pharma, Inc. annual revenue for 2024 was 221.9 M, a 2285.27% increase from 2023.
- BridgeBio Pharma, Inc. annual revenue for 2023 was 9.3 M, a 88.02% decrease from 2022.
- BridgeBio Pharma, Inc. annual revenue for 2022 was 77.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BridgeBio Pharma, Inc. Earnings — FAQ
BridgeBio Pharma, Inc. (BBIO) earnings over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's earnings history?
The chart and table above show BridgeBio Pharma, Inc.'s earnings by year and by quarter, including the growth rate.